Concepedia

Kathryn E. King

KE

11

Publications

3.2K

Citations

11

H-Index

1997

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

John Innes Centre

United States Food and Drug Administration

National Institute on Deafness and Other Communication Disorders

Kathryn E. King is an author at Center for Drug Evaluation and Research specializing in medicine, cell signaling, and cell biology.

ORCID

Top concepts

Publications per year

1997–2021

11

Publications

11

The <i>Arabidopsis GAI</i> gene defines a signaling pathway that negatively regulates gibberellin responses

Jinrong Peng, Pierre Carol, Donald E. Richards et al. · Genes & Development · 1997 · 1.2K citations · Full text

, , +13

Gibberellin regulates <i>Arabidopsis</i> seed germination via <i>RGL2</i> , a <i>GAI/RGA</i> -like gene whose expression is up-regulated following imbibition

Sor-Cheng Lee, Hui Cheng, Kathryn E. King et al. · Genes & Development · 2002 · 633 citations · Full text

H<scp>OW</scp>G<scp>IBBERELLIN</scp>R<scp>EGULATES</scp>P<scp>LANT</scp>G<scp>ROWTH AND</scp>D<scp>EVELOPMENT</scp>: A Molecular Genetic Analysis of Gibberellin Signaling

Donald E. Richards, Kathryn E. King, Tahar Aït-Ali et al. · Annual Review of Plant Physiology and Plant Molecular Biology · 2001 · 513 citations

Gibberellins Are Not Required for Normal Stem Growth in <i>Arabidopsis thaliana</i> in the Absence of GAI and RGA

Kathryn E. King, Thomas Möritz, Nicholas P. Harberd · Genetics · 2001 · 286 citations · Full text

ΔNp63α functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes

Kathryn E. King, Roshini M. Ponnamperuma, Toshiharu Yamashita et al. · Oncogene · 2003 · 139 citations

, , +11

Rows per page

1–5 of 11